Gene · 28898
Papers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression. | Genes (Basel) | 2023 | 37372414 | PubTator, text mining | PubMed |
| A potential cost of evolving epibatidine resistance in poison frogs. | BMC Biol | 2023 | 37370119 | PubTator, text mining | PubMed |
| Chain-specificity of laminin α1-5 LG45 modules in the recognition of carbohydrate-linked receptors and intramolecular binding. | Sci Rep | 2023 | 37369727 | PubTator, text mining | PubMed |
| Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence. | mBio | 2023 | 37366623 | PubTator, text mining | PubMed |
| Contributions of coxsackievirus adenovirus receptor to tumorigenesis. | Biochem Soc Trans | 2023 | 37306404 | PubTator, text mining | PubMed |
| Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α4β1 Integrin. | Int J Mol Sci | 2023 | 37298541 | PubTator, text mining | PubMed |
| A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8. | Proc Natl Acad Sci U S A | 2023 | 37279271 | PubTator, text mining | PubMed |
| Epigenetic suppression of PGC1α (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas. | Nat Commun | 2023 | 37277330 | PubTator, text mining | PubMed |
| Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments. | Fundam Clin Pharmacol | 2023 | 37259891 | PubTator, text mining | PubMed |
| Tubulin Polyglutamylation by TTLL1 and TTLL7 Regulate Glutamate Concentration in the Mice Brain. | Biomolecules | 2023 | 37238654 | PubTator, text mining | PubMed |
| High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro. | J Neuroinflammation | 2023 | 37221552 | PubTator, text mining | PubMed |
| TP53BP1, a dual-coding gene, uses promoter switching and translational reinitiation to express a smORF protein. | iScience | 2023 | 37216125 | PubTator, text mining | PubMed |
| Macromolecular α-glucans with α-1,3/α-1,4 branching structures produced using dual glycosyltransferases: Elucidation of physicochemical and slowly digestible properties. | Int J Biol Macromol | 2023 | 37201882 | PubTator, text mining | PubMed |
| Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets. | Front Immunol | 2023 | 37180117 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis. | Clin Proteomics | 2023 | 37179321 | PubTator, text mining | PubMed |
| Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System. | Cancers (Basel) | 2023 | 37173970 | PubTator, text mining | PubMed |
| Analysis of variations in the bronchovascular pattern of the lingular segment to explore the correlations between the lingular segment artery and left superior division veins. | Front Surg | 2023 | 37151862 | PubTator, text mining | PubMed |
| Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis. | Front Immunol | 2023 | 37143680 | PubTator, text mining | PubMed |
| Substrate-specific effects of natural genetic variation on proteasome activity. | PLoS Genet | 2023 | 37126494 | PubTator, text mining | PubMed |
| Increased Motility and Suppression of Ex Vivo-Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis. | Cell Mol Gastroenterol Hepatol | 2023 | 37085136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28898/papers?page=6